Pantai Hospital (KL) introduces Outpatient Parenteral Antimicrobial Therapy (OPAT)

August 13, 2024

healthcaretoday, Pantai Hospital, PHKL, outpatient service, intravenous antimicrobial therapy, OPAT treatment,

A Pantai Hospital Kuala Lumpur OPAT patient being outfitted with a Baxter elastomeric pump bottle that infuses antibiotics over a 24-hour period.

Pantai Hospital Kuala Lumpur (PHKL) has officially introduced its Outpatient Parenteral Antimicrobial Therapy (OPAT) service, offering an innovative treatment option that enhances patient care. Reaffirming PHKL’s commitment in offering its patients value-based care, OPAT is a practical, safe and effective outpatient service that has established benefits for an increasingly wide range of conditions and infections.

According to guidelines issued by the Malaysian Ministry of Health, OPAT is defined as a service that enables patients who are stable and suitable for discharge from hospital – but who require continued intravenous antimicrobial therapy – to be allowed to continue their treatment as outpatients. This ensures they receive high-quality care without the need for prolonged hospital stays.

PHKL started building its OPAT services in 2023, refining the setup and processes of its operations in adherence to ministerial guidelines, with emphasis on the importance of a clear diagnosis, treatment plan, and follow-up care.

“Since its inception, our OPAT service has seen positive outcomes in three main areas for patients: reducing the length of hospital stays, minimizing healthcare costs, and a reduction in hospital acquired infection," says Dr Anusha Shunmugarajoo (pix), Infectious Diseases Consultant at PHKL.

To determine eligibility, patients are also evaluated based on their hemodynamic stability, willingness to return daily for treatment, and proximity of stay. Once eligible, the patient will be under the care of Dr Anusha and her team. Treatment involves the insertion of a central catheter, ensuring a safer way of administering antibiotics and reducing the risk of thrombophlebitis.

Where the pre-OPAT median hospital stay has been around 18 days, there has been a reduction in similar cases to just five days since the implementation of OPAT. Costs for patients have also lessened by up to 10%-15%, depending on the type of antibiotics used and any isolation requirements. There have been low re-infection rates with OPAT, owing to consistent and timely administration of medication, a tailored therapy treatment and dedicated care.

The OPAT treatment service is a key part of PHKL’s efforts in antimicrobial stewardship, which promotes a judicious prescription and administration of antimicrobials (including antibiotics) following evidence-based guidelines. This also aligns with a global push towards combating antibiotic resistance.

By reducing the need for extended hospital stays, our OPAT service is designed to contribute towards a more sustainable healthcare system, reducing carbon footprint and cost without compromising the quality of care.
As a tertiary healthcare provider, PHKL is committed to providing cutting-edge medical services and improving patient outcomes through a sustainable approach. The introduction of OPAT represents a significant advancement in outpatient care, offering our patients a safe, effective, and convenient alternative to traditional hospital-based therapy.

EXPLORE FURTHER

healthcaretoday, Damai Pain Care & Wellness, Basic Life Support course, American Heart Association, Universiti Malaysia Sabah, cardiopulmonary resuscitation, cardiac arrest, emergency response, Automated External Defibrillator, CPR, save lives, cardiac care, teachers, coaches, lifeguards, caregivers, police officers, medical professionals,

Pantai Hospital (KL) introduces Outpatient Parenteral Antimicrobial Therapy (OPAT)

EXPLORE FURTHER

Maaedicare fundraiser ball delivers RM500,000 boost for kidney, cardiac patients

National Heart Institute (IJN) introduces Evolut FX device to treat aortic stenosis

Learn to save lives: Join our basic life support (BLS) course

Duopharma Biotech explores collaboration in halal pharmaceuticals at Doha roundtable

Regency Specialist Hospital enters Malaysian Book of Records with diabetes screening campaign

Sunway Medical Centre launches CSR radiotherapy program for cancer in Sarawak

EncoreMed shines brights at APHM conference, redefining healthcare with unified hospital digital solution

DKSH offers support to shelter home for children

New ERT Nexviazyme approved for treatment of Pompe disease

Aurelius Healthcare and Rizman Ruzaini enhance staff uniforms across departments

Taking quality lumbar support to new heights

DKSH Malaysia - Botrem partner to revolutionize skin rehabilitation

Duopharma Biotech - Owen Mumford partners to distribute medical devices

Columbia Asia sets foot in Bukit Jalil

Sunway Medical Centre Velocity introduces robotic surgery service

Danone Malaysia - the first food company to be certified B Corporation

Preserving female cancer patients' fertility via cryopreservation

Monurol (Fosfomycin Trometamol) receives DCA approval for transrectal prostate biopsy in adult men

Roche-MUIS announce funding for breast cancer patients

5-year-old Khaivan gains hearing ability through cochlear implant surgery

Mahkota Medical Centre earns CCPC accreditation for breast cancer

UMW Toyota's generous donation bolsters cancer society's vital services